News Brexit could delay drug launches, former MHRA chief warns Britain will be in "second or third tier" of drug launches, experts warn.
News Hunt under pressure over plans to quit EMA Britain could be in "second rank" of medicines access, warn MPs.
Views & Analysis Could the EMA really stay in London? After the UK voted to leave Europe, its seems obvious that the European Medicines Agency will have to leave London - but GSK’s Andrew Witty and others hope it might stay.
News Vtesse's rare disease drug set for UK early access Vtesse drug "promising" treatment for NPC disease, says regulator.
Views & Analysis Meeting pharmacovigilance standards in the US and Europe Examining statistics on recent inspections gives insight into the issues commonly faced.
News UK regulator updates guidance for health apps MHRA's updated guidance aims to clarify medical device classification.
News Infex chases after Insmed with bronchiectasis trial win UK biotech Infex is in hot pursuit of Insmed's Brinsupri, the only approved therapy for non-CF bronchiectasis, with its quarterly-dosed antibody.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
